chevron_leftBack
As of 18 June 2026, Alterola Biotech, Inc. has a market cap of $7.55M USD, ranking #42742 globally and #966 in the United Kingdom.
It ranks #3775 in the Healthcare sector, and #262 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$7.55MUSD
Enterprise Value
$9.62MUSD
Net Income (TTM)
-$2.78MUSD
PB Ratio
-3.4
Company Profile
Country (HQ)
Sector
Healthcare
CEO
David Hitchcock
open_in_new
Website
alterola-abti.com/
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | - | 0% | 2K% | -97% | 42% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ABTI
Alterola Biotech Inc
ISIN: US02152V1035
Shares Out.:
Shares Outstanding:
1.46B1
Shares Float:
139.938M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0051 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Alterola Biotech, Inc.
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech, Inc. is based in Birkenhead, the United Kingdom.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
LSE: HIK
|
$3.98B
53K%
2.98B GBP
|
10.3
|
|
LSE: AGY
|
$869.89M
11K%
652.25M GBP
|
-
|
|
LSE: APN
|
$716.85M
9K%
537.5M GBP
|
19.5
|
|
LSE: ANCR
|
$306.64M
4K%
229.92M GBP
|
73.8
|
|
LSE: IMM
|
$34.95M
363%
26.2M GBP
|
-
|
|
LSE: SBTX
|
$33.7M
346%
25.27M GBP
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.2B
492K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
391K%
|
-
|
|
SHE: 002001
|
$15.88B
210K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.25B
149K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.13B
147K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.11B
121K%
61.6B CNY
|
80.6
|
chevron_leftBack